Researchers at the David H. Koch Institute for Integrative Cancer Research at MIT and the Dana-Farber/Harvard Cancer Center are embarking on an unusual alliance that will combine the research strengths of both organizations to yield new treatments and insights into two highly lethal cancers. Jeffrey Clark, HMS associate professor of medicine at Massachusetts General Hospital, is quoted.
